AGT and triple-A syndrome: The contribution of Ang II-associated signals to EGFR transactivation that target LOX is supported by several mouse models, human carcinoma cell lines and human tumor tissue relevant to the pathomechanisms of AAA, vascular remodeling and hypertension, and to primary and metastatic lung carcinoma.